 | Galmed Pharmaceuticals Ltd. | |||
| NCM : GLMD || Location: Israel | ||||
$0.37-0.01 (-1.58%) |
0.02 M | 0.37 - 0.38 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.039 M |
| March 15, 2024 | 0.006 M |
| Feb. 29, 2024 | 0.041 M |
| Feb. 15, 2024 | 0.076 M |
| Jan. 31, 2024 | 0.011 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.33 | -0.98 | -200.25% |
| 09/30/2023 | -0.28 | -0.24 | 12.85% |
| 06/30/2023 | -0.35 | -0.95 | -173.93% |
| 03/31/2023 | -1.53 | -1.09 | 28.76% |
| 12/31/2022 | -2.14 | -1.50 | 29.97% |
GLMD Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 6.010M | Shares Float | 5.777M |
| Short Float | 0.039M | Market Cap | 2.22M |
| Institution ownership | 9.44% | Insider ownership | 3.868% |
| Earnings Date | 05/08/2024 | Cash Per Share | ? |
| Trailing EPS | -2.50 | Forward EPS | -1.03 |